par Michel, Olivier 
;Doyen, Virginie ;Corazza, Francis ;Dinh, Duc H D
Référence BMC Pharmacology and Toxicology, 15, 1, 60
Publication Publié, 2014-11
;Doyen, Virginie ;Corazza, Francis ;Dinh, Duc H DRéférence BMC Pharmacology and Toxicology, 15, 1, 60
Publication Publié, 2014-11
Article révisé par les pairs
| Titre: |
|
| Auteur: | Michel, Olivier; Doyen, Virginie; Corazza, Francis; Dinh, Duc H D |
| Informations sur la publication: | BMC Pharmacology and Toxicology, 15, 1, 60 |
| Statut de publication: | Publié, 2014-11 |
| Sujet CREF: | Pneumologie |
| Mots-clés: | Anti-TNF |
| Corticosteroids | |
| Endotoxin inhalation | |
| Neutrophilic inflammation | |
| MeSH keywords: | Adalimumab |
| Administration, Inhalation | |
| Adult | |
| Antibodies, Monoclonal, Humanized -- pharmacology | |
| Cell Count | |
| Escherichia coli | |
| Female | |
| Humans | |
| Inflammation -- chemically induced -- immunology | |
| Lipopolysaccharides | |
| Macrophages -- drug effects -- immunology | |
| Male | |
| Methylprednisolone -- pharmacology | |
| Neutrophils -- drug effects -- immunology | |
| Sputum -- cytology | |
| Tumor Necrosis Factor-alpha -- antagonists & inhibitors | |
| Note générale: | SCOPUS: ar.j |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:2050-6511 |
| info:doi/10.1186/2050-6511-15-60. | |
| info:pii/2050-6511-15-60 | |
| info:scp/84924422389 | |
| info:pmid/25371053 | |
| PMC4236481 |
